*Present address: Department of Medicine, Mansoura University Hospital, Mansoura, Egypt. from 37 to 84 years (median 63) and the duration of disease from one to 27 years (median 9). Twentyfour patients had extra-articular manifestations including subcutaneous nodules, peripheral neuritis, and vasculitic skin ulcers. Immunoglobulin M rheumatoid factor (IgMRF) was positive in 42 patients. All patients were treated with nonsteroidal anti-inflammatory drugs (NSAID), and 20 of them were receiving additional treatment with corticosteroids in the form of prednislone 2-5-10 mg/day.
The overall disease activity of the RA patients was assessed by means of a composite activity index (CAI) which included both clincal and laboratory markers combining to form a single score.'°1 1 With the CAI score RA patients were classified into slightly, moderately, and highly active groups.
A group of 15 25 ,umoVl NBT, and 0-01 units xanthine oxidase. Xanthine oxidase (150 U/l). Xanthine 100 ,umol/l. SOD standard (2900 U/mg protein).
Assay. SOD activity in PMNLs (=20x109) and MNCs (=10x109) was assayed by the method of Beauchamp and Fridovich.16 SOD is detected by its ability to inhibit the reduction of NBT mediated by O-which is generated during the oxidation of xanthine by xanthine oxidase. The reduction of NBT was followed at 560 nm at 25°C with an SP1800 spectrophotometer (Pye Unicam Ltd, Cambridge, England). The decrease in the rate of NBT reduction/min was plotted against the amount of SOD. Comparison between SOD activity in PMNLs and MNCs from patients and controls (Table 1) The median SOD activity in the PMNLs of the RA patients (0-8 U/mg protein) was significantly higher than that of the control group (0-6 U/mg protein, p<0.02). The median SOD activity in the MNCs of the RA patients was also significantly higher (1.7 U/mg protein) than that of the control group (1 -2 U/mg protein, p<0.005).
SOD activity in PMNLs and MNCs from patients with RA in relation to the factors listed below Patients' age (years). There was no correlation between the patients' age and SOD activity in PMNLs and MNCs. Our finding of increased SOD activity in PMNLs, but not MNCs, from RA patients treated with corticosteroids was not related to any of the factors studied. This finding is of interest since the increase in SOD activity might prevent excessive release of OF2 and therefore protect against the effects of this radical.5`8 This mechanism might explain, at least in part, the beneficial effect of corticosteroids.
It is of additional interest that cortcosteroids are potent enzyme inducers29 and cortisol has been shown to inhibit the production of O-by PMNLs.30 This inhibition could be the result of induced SOD activity in PMNLs. This finding has also been indirectly confirmed3" by the demonstratic-n of decreased killing ability by PMNLs incubated with cortisol. Moreover, the phagocytic activity of PMNLs is defective in RA patients treated with prednisolone.32
These findings together with our own may account, at least in part, for the susceptibility to infection of RA patients,33 particularly those treated with corticosteroids.
Further work is under way to establish the exact role of leucocyte SOD and to assess its importance and possible applications.
